RicardoLima BarrosCostaMD

Oncology • Tampa, FL

Breast Cancer, Hematologic Oncology

Assistant Member at Moffitt Cancer Center - Breast Oncology Department

Request Appointment

Overview of Dr. Costa

Dr. Ricardo Costa is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Federal University of Pernambuco Faculty of Medicine and has been in practice 13 years. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 50 publications and over 500 citings.

Office
10920 N. McKinley Drive
Tampa, FL 33612
Book by Phone+1(813) 547-6792
Is this information wrong?

Education & Training

Allegheny Health Network Medical Education Consortium (WPH/AGH)Fellowship, Hematology and Medical Oncology, 2008 - 2011
East Tennessee State University/Quillen College of MedicineResidency, Internal Medicine, 2005 - 2008
Federal University of Pernambuco Faculty of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2017 - 2025
IL State Medical License 2015 - 2017
PA State Medical License 2008 - 2011
American Board of Internal Medicine Medical Oncology

Clinical Trials

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer Start of enrollment: 2022 Aug 26
Recruiting
Phase 1
Roles: Principal Investigator, Contact

Publications & Presentations

PubMed

A Cohort Study of the Antitumor Efficacy and Toxicity Profile of Alpelisib for Metastatic or Locally Advanced HR+, HER2- Breast Cancer: A Single-Institution Experience.
Humaira Sarfraz, Shahla Bari, Junmin Whiting, Melissa Sur, Qianxing Mo, Melissa Armitage, Ricardo L B Costa> ;Oncology. 2023 Nov 27
2 citations
Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between.
Hyo Sook Han, Praveen Vikas, Ricardo L B Costa, Nusrat Jahan, Ammanuel Taye, Erica M Stringer-Reasor> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani...> ;Nature Medicine. 2023 Dec 1
16 citations
Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial.
Hatem Soliman, Deanna Hogue, Hyo Han, Blaise Mooney, Ricardo Costa, Marie C Lee, Bethany Niell, Angela Williams, Alec Chau, Shannon Falcon, Aixa Soyano, Avan Armaghani...> ;Nature Medicine. 2023 Feb 1
A Real-World Data Retrospective Cohort Study of HER2-positive, Early-Stage Breast Cancer in Patients 70 Years of Age or Older: Natural History, Treatment Patterns, and...
Shahla Bari, Jiannong Li, Di Kang, Zena Jameel, Brian J Czerniecki, Ricardo L B Costa> ;Clinical Breast Cancer. 2023 Jun 1
Retrospective Study of Treatment Patterns and Natural History of Patients with T1a/b N0 Triple-Negative Breast Cancers: A Single-Institution Experience.
Langfeier Liu, Nicholas Lewis, Weihong Sun, Junmin Whiting, Susan Hoover, Costa, R.> ;Oncology. 2023 Jan 1
1 citations
Long-Term CD4T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study.
Corey Gallen, Christopher W Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L Cubitt, Shari Pilon-Thomas, Anna R Giuliano, Brian J Czerniecki, Ricardo L B...> ;Vaccines. 2022 Nov 15
6 citations
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinoma.
Ganesan Ramamoorthi, Krithika Kodumudi, Colin Snyder, Payal Grover, Hongtao Zhang, Mark I Greene, Amrita Basu, Corey Gallen, Doris Wiener, Ricardo L B Costa, Hyo S Han...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
2 citations
A Real-World Data Retrospective Cohort Study of Low Estrogen Receptor-Positive Early Breast Cancer: Natural History and Treatment Outcomes.
Shahla Bari, David Boulware, Jiannong Li, Loretta Loftus, Aixa Soyano Muller, Zena Jameel, Hung Khong, Brian J Czerniecki, Ricardo L B Costa> ;Breast Cancer. 2022 Jan 1
2 citations
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective S...
Elie Barakat, András Bibok, Anupam Rishi, Altan Ahmed, Jessica M. Frakes, Sarah E. Hoffe, Avan Armaghani, Aixa E. Soyano, Ricardo Costa, Ghassan El-Haddad, Junsung Cho...> ;Advances in Radiation Oncology. 2022 Jan 1
7 citations
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
Kamran Ahmed, Young-Chul Kim, John A. Arrington, Sungjune Kim, Michelle DeJesus, Aixa E. Soyano, Avan Armaghani, Ricardo Costa, Hung T. Khong, Loretta Loftus, Marilin ...> ;Advances in Radiation Oncology. 2021 Nov 1
8 citations
Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia
James Sun, Xiaojun Zhong, Junjie Ma, Weihong Sun, Hyo S. Han, Hatem Soliman, Loretta Loftus, Ricardo Costa, Avan Armaghani, Aixa E. Soyano‐Muller, Brian J. Czerniecki,...> ;Cancer Medicine. 2021 Sep 30
5 citations
A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers
Laura B. Oswald, Brandy Arredondo, Mika Kadono, Dinorah Martinez-Tyson, Cathy D. Meade, Frank J. Penedo, Michael H. Antoni, Hatem Soliman, Ricardo Costa, Heather S.L. Jim> ;Cancer Medicine. 2021 Jun 24
5 citations
Novel evolutionary dynamics of small populations in breast cancer adjuvant and neoadjuvant therapy
Yael Artzy-Randrup, Tamir Epstein, Joel S. Brown, Ricardo Costa, Brian J. Czerniecki, Robert A. Gatenby> ;NPJ Breast Cancer. 2021 Mar 11
17 citations
Disseminated cancer cells in breast cancer: Mechanism of dissemination and dormancy and emerging insights on therapeutic opportunities.
Ganesan Ramamoorthi, Krithika Kodumudi, Corey Gallen, Nadia Nocera Zachariah, Amrita Basu, Gabriella Albert, Amber Beyer, Colin Snyder, Doris Wiener, Ricardo Costa, Br...> ;Seminars in Cancer Biology. 2021 Feb 21
26 citations
A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast Cancer
Hatem Soliman, Deanna Hogue, Hyo S. Han, Blaise Mooney, Ricardo Costa, Marie C. Lee, Bethany L. Niell, Angela Williams, Alec Chau, Shannon Falcon, Nazanin Khakpour, Ro...> ;Clinical Cancer Research. 2021 Feb 15
19 citations
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
Yongsheng Jia, Krithika Kodumudi, Ganesan Ramamoorthi, Amrita Basu, Colin Snyder, Doris Wiener, Shari Pilon-Thomas, Payal Grover, Hongtao Zhang, Mark I. Greene, Qianxi...> ;Molecular Therapy. 2021 Jan 5
9 citations
A systematic review and meta-analysis of selected toxicity endpoints of alpelisib.
Misty Shields, Qianxing Mo, Melissa Armitage, Susan C. Sharpe, Ricardo Costa> ;Oncotarget. 2020 Oct 20
4 citations
Circulating immune cell dynamics in patients with triple negative breast cancer treated with neoadjuvant chemotherapy
Sarah M. Talamantes, Eric Xie, Ricardo Costa, Melissa Chen, Alfred Rademaker, Cesar A. Santa-Maria> ;Cancer Medicine. 2020 Aug 5
Clinical development of immunotherapies for HER2breast cancer: a review of HER2-directed monoclonal antibodies and beyond.
Ricardo L B Costa, Brian J Czerniecki> ;NPJ Breast Cancer. 2020 Jan 1
63 citations
Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial
Benedito A. Carneiro, Bhavana Konda, R. Costa, Ricardo Costa, Vinay Sagar, Demirkan B. Gursel, Lawrence S. Kirschner, Young Kwang Chae, Sarki A. Abdulkadir, Alfred Rad...> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Dec 1
35 citations
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in ...
Krithika Kodumudi, Ganesan Ramamoorthi, Colin Snyder, Amrita Basu, Yongsheng Jia, Amber Beyer, Doris Wiener, Lian Lam, Hongtao Zhang, Mark I. Greene, Ricardo Costa, Br...> ;Frontiers in Immunology. 2019 Aug 14
11 citations
A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2 + breast cancer
Ricardo Costa, Saif Zaman, Susan C. Sharpe, Irene Helenowski, Colleen Shaw, Hyo S. Han, Hatem Soliman, Brian J. Czerniecki> ;Drug Design, Development and Therapy. 2019 Jan 14
9 citations
Posterior reversible encephalopathy syndrome and takotsubo cardiomyopathy associated with lenvatinib therapy for thyroid cancer: a case report and review.
Young Kwang Chae, Lauren Chiec, Scott K. Adney, Josh Waitzman, Ricardo Costa, Benedito A. Carneiro, Maria Matsangou, Mark Agulnik, Peter Kopp, Frank Giles> ;Oncotarget. 2018 Jun 15
59 citations
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis.
Matthew N. Mills, G.Q. Yang, Daniel E. Oliver, C. Liveringhouse, Kamran Ahmed, Amber G. Orman, Christine Laronga, Susan J. Hoover, Nazanin Khakpour, Ricardo L.B. Costa...> ;European Journal of Cancer. 2018 Jun 2
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida